Timing of Adjuvant Chemotherapy After Gastrectomy in Patients With Stage II to III Gastric Cancer: A Target Trial Emulation Study
Initiating AC 7-12 weeks after D2 gastrectomy appeared to be noninferior to initiation within 6 weeks with respect to 5-year mortality in stage II to III GC; however, residual confounding cannot be excluded and the findings require validation in further studies.
Authors
- Yan Ding (ORCID: https://orcid.org/0000-0002-0136-8275)
- Hui Xu (ORCID: https://orcid.org/0000-0002-0421-8125)
- Zhijun Wu (ORCID: https://orcid.org/0000-0003-3086-3889)
- Tai Ma (ORCID: https://orcid.org/0000-0003-0911-850X)
- Min Tao (ORCID: https://orcid.org/0000-0001-9439-2153)
- Lian Jin
- Zhao Yang Dong (ORCID: https://orcid.org/0000-0001-9659-0858)
- Cheng Zhang (ORCID: https://orcid.org/0000-0001-7665-8675)
- Jiayi Wang (ORCID: https://orcid.org/0000-0003-1688-2864)
- Chen Yao (ORCID: https://orcid.org/0000-0003-4224-5535)
- Xin Xiao (ORCID: https://orcid.org/0000-0002-9274-137X)
- Man Wu (ORCID: https://orcid.org/0000-0003-1332-3792)
- Qiaoling Xu
- Ke Liu (ORCID: https://orcid.org/0009-0004-0089-1410)
Institutions
- Anhui Medical University (CN)
- Minhang District Central Hospital (CN)
- Zhuhai People's Hospital (CN)
- Chaohu Hospital of Anhui Medical University (CN)
- Anhui Institute of Architectural Research and Design (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Cixian People's Hospital (CN)
- Anshan Hospital (CN)
Publication Details
- Journal
- JCO Precision Oncology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1200/po-25-00664
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.52